Bioassay Containment Development Engineer 
Drug Discovery World
NOVEMBER 30, 2023
Lightcast is developing a novel, programmable microfluidic platform that allows precise and highly flexible control of individual microdroplets using software-generated light patterns. GSK has developed high-throughput mammalian and E.
Drug Discovery World
MAY 4, 2023
The potential of drug targets Over the next 50 years, new targets emerged and drugs were developed against them. Here, new bioassay technologies helped testing, but more definite answers were required. Often drug targets already validated in academic literature are picked up for drug discovery and development efforts.
The Pharma Data
MAY 13, 2021
Fructose Containing Sugars at Normal Levels of Consumption Do Not Effect Adversely Components of the Metabolic Syndrome and Risk Factors for Cardiovascular Disease. Fructose as a key player in the development of fatty liver disease. How does brain insulin resistance develop in Alzheimer’s disease? Journal of Food Engineering.
Expert insights. Personalized for you.
59 
Let's personalize your content